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A B S T R A C T   
Background: Despite disproportionately high rates of smoking among people in residential substance use disorder 
(SUD) treatment, few receive tobacco cessation services. Little is known about how smoking among treatment 
staff may impact this disparity. We explored the relationship between staff tobacco use and client tobacco use. 
Additionally, we examined the relationship between staff tobacco use and tobacco-related services reported by 
staff and clients. 
Methods: Staff (n = 363) and clients (n = 639) in 24 California publicly-funded residential SUD treatment pro-
grams were surveyed in 2019–20. Staff self-reported current tobacco use, as well as their beliefs, self-efficacy, 
and practices regarding smoking cessation. Clients reported their tobacco use and they services received while 
in treatment. Regression analyses examined the adjusted and unadjusted associations between staff and client 
tobacco use and other outcomes. 
Results: Use of any tobacco product by staff ranged from 0% to 100% by program, with an average of 32% across 
programs. Adjusted analyses found that higher rates of staff tobacco use were associated with higher rates of 
client tobacco use, and with fewer clients receiving tobacco-related counseling. In programs that had higher rates 
of staff tobacco use, staff were less likely to believe that clients should quit smoking in treatment and had lower 
self-efficacy to address smoking. 
Conclusion: Higher rates of tobacco use among staff are associated with higher rates of client tobacco use and 
fewer clients receiving cessation counseling. Efforts to reduce tobacco use among SUD clients should be sup-
ported by efforts to reduce tobacco use among staff. SUD treatment programs, and agencies that fund and 
regulate those programs, should aim to reduce the use of tobacco products among staff.   
1. Introduction 
Smoking rates among persons with substance use disorders (SUD) are 
higher than in the general population (Richter, Ahluwalia, Mosier, 
Nazir, & Ahluwalia, 2002; Smith, Mazure, & McKee, 2014), and showed 
no decline from 2002 to 2014 (Weinberger et al., 2018). This disparity 
suggests that population level tobacco control strategies such as edu-
cation and taxation have limited effect among people with SUDs 
(Warner, 2006). Smokers with SUDs smoke more heavily (Ward, Kedia, 
Webb, & Relyea, 2012), have a harder time quitting smoking (Wein-
berger, Funk, & Goodwin, 2016), and experience both excess and pre-
mature tobacco-related mortality (Bandiera, Anteneh, Le, Delucchi, & 
Guydish, 2015). 
About 2.4 million Americans enter SUD specialty treatment annually 
(SAMHSA, 2017), and among those the smoking prevalence is about 
70% (Guydish, Le, Gubner, Williams, & Delucchi, 2019). Receiving 
smoking cessation services while in SUD treatment is associated with 
improvement in SUD outcomes (Baca & Yahne, 2009; Prochaska, 
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Delucchi, & Hall, 2004) and continued smoking is associated with 
relapse to substance use (Weinberger et al., 2017). However, in one 
review only 40% of SUD programs offered cessation counseling and only 
26% offered cessation medication (Knudsen, 2017). Resource limita-
tions, such as lack of staff time or training, are commonly cited to 
explain this discrepancy (Sheals, Tombor, McNeill, & Shahab, 2016). 
Some staff believe that quitting smoking poses a risk to sobriety, or that 
clients are not interested in quitting (Guydish, Passalacqua, Tajima, & 
Manser, 2007), although such beliefs have been debunked (Prochaska, 
2011). 
One reason why tobacco services are not delivered in SUD programs 
may be the level of tobacco use among staff (Cookson et al., 2014; 
Guydish et al., 2007). Several papers report SUD staff smoking rates 10% 
higher than that of the U.S. general population (Bobo & Davis, 1993; Gill 
& Bennett, 2000; Olsen, Alford, Horton, & Saitz, 2005; Rothrauff & Eby, 
2011). Other papers report staff smoking rates only slightly higher than 
population rates (Chisolm et al., 2010; Laschober, Muilenburg, & Eby, 
2015; Muilenburg, Laschober, Eby, & Moore, 2016; Pagano, Guydish, 
Le, et al., 2016). Knudsen, Studts, and Studts (2012), surveying coun-
selors from over 400 programs, reported a staff smoking rate (20%) very 
close to the population rate at that time. Laschober et al. (2015) sur-
veyed counselors from over 200 programs, and reported a 21% staff 
smoking rate. Reports from the UK and Australia found staff smoking 
rates 10–25% higher than the general population (Cookson et al., 2014; 
Skelton et al., 2017). 
Related questions are whether staff smoking is associated with client 
smoking rates, and whether staff smoking rates are associated with 
client receipt of tobacco-related services. While we found no studies for 
the former question, several papers have explored the latter. Early 
studies of staff suggest that those who smoke, as compared to non- 
smokers, have more resistant views towards smoking as a treatment 
issue (Bobo, Slade, & Hoffman, 1995; Campbell, Krumenacker, & Stark, 
1998). Staff who smoke less often provided tobacco-related services to 
clients (Knudsen & Studts, 2010), and more often believed that clients 
are not interested in quitting smoking (Laschober et al., 2015; Skelton 
et al., 2017). One study found that counselor smoking status was not 
associated with providing cessation counseling to clients (Knudsen et al., 
2012). 
Studies of both staff and clients, in the same program, may illuminate 
any relationship between staff smoking and providing tobacco-related 
services to clients. Bernstein and Stoduto (1999) surveyed staff and 
clients after initiating a choice-based smoking program within a treat-
ment facility. While 38% of the clients had a counselor who smoked, 
staff smoking was not associated with client participation in the smoking 
program. Olsen et al. (2005) found that 97% of counselors reported 
providing smoking cessation counseling to clients, but only 48% of cli-
ents reported receiving such counseling. Counselor smoking status was 
not associated with client receipt of cessation counseling. 
While prior literature has focused on smoking combustible ciga-
rettes, it may be helpful to consider use of other tobacco products since, 
among SUD clients, recent use of any tobacco product is 4–5% higher 
than use of combustible cigarettes alone (Guydish et al., 2016; Guydish 
et al., 2020). Assessing the relationship between tobacco use among staff 
and among clients, and between staff tobacco use and client receipt of 
tobacco-related services, requires data collection among staff and clients 
in the same program. It also requires data collection in a number of 
programs because the program becomes the unit of analysis. For these 
reasons, studies using client level variables aggregated to the program 
level, such as the association between staff and client tobacco use, are 
infrequent in the SUD treatment literature. 
Such studies may be important, however, with respect to tobacco use 
in SUD treatment. High rates of tobacco use among staff may normalize 
tobacco use, hinder tobacco policy development or enforcement and, 
where tobacco using staff are reluctant to counsel clients about tobacco 
use, limit the level of tobacco-related services provided. In that case, 
reducing tobacco use among staff may be necessary in order to reduce 
tobacco use among clients. To assess the association between staff to-
bacco use and client tobacco use we surveyed both staff and clients in 24 
California publicly-funded residential SUD treatment programs. As a 
secondary aim, we examined whether tobacco use among staff was 
associated with measures of tobacco-related services as reported by both 
staff and clients. 
2. Methods 
2.1. Program recruitment 
We collected data between January 2019 and July 2020 from 24 
California licensed residential SUD programs recruited in the course of 
three studies designed to improve tobacco-related policies and services. 
Program inclusion criteria were for California state-licensed residential 
SUD programs, where the Program Director indicated willingness to 
participate in a tobacco-related intervention. The 24 programs were 
located in 12 of California’s 58 counties, ranging from Lake County in 
the North to San Diego County in the South. Additional information 
about program selection and recruitment is reported in Guydish et al. 
(2020). 
2.2. Participants 
Participants included program clients, staff, and directors. Eligible 
clients were all those enrolled in the program at the time of data 
collection. Eligible staff were all full and part time paid staff working in 
the program. As three program directors led more than one program, 20 
directors represented the 24 programs. 
2.3. Procedures 
Site visits to collect client surveys were generally completed in one 
day. Program directors reported the number of clients enrolled in the 
program, for use in calculating response rates. Research staff reviewed a 
study information sheet with clients in small groups, and gave each 
client a computer tablet survey with a pre-populated ID number. The 
client reviewed the study information sheet on the tablet and used a 
button to consent or to decline participation. The anonymous survey 
took about 30 min. After the survey, research staff assessed clients’ 
expired carbon monoxide (CO) was using a Bedfont piCO™ hand-held 
monitor (Bedfont Scientific Ltd., 2018). At four programs where no 
site visit occurred due to COVID restrictions, clients completed the same 
procedures on a computer provided by their program, however CO data 
were not collected because research staff were not present on site. 
Participants received a $20 gift card. 
Directors at each program provided the research team with staff 
work email addresses, r, and staff were then invited by email to complete 
the confidential online survey. After three weekly reminders, the 
research team used additional strategies approved by the Director. For 
example, having the Director send a reminder to non-responders, or 
having the research team re-send the invitation to non-responders. Staff 
respondents received a $25 gift card. 
Program directors completed an online tobacco policy survey. Study 
procedures were approved by the Institutional Review Board of the 
University of California San Francisco. 
2.4. Measures 
2.4.1. Client measures 
In addition to demographic characteristics, participants reported 
their health insurance coverage. The California Medicaid program 
(Medi-Cal) covers residential SUD treatment (DHCS, 2020), and also 
covers smoking cessation counseling and medication (DHCS, 2016). All 
three study surveys asked participants whether they sought treatment 
mainly for a substance use problem, for both substance use and mental 
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health problems, or for some other problem. However, the survey for 
one study also allowed respondents to say they were in treatment for 
mental health problems only. For the purpose of analyses, these cases 
were combined into the substance use and mental health category. 
Current smoking status was defined by asking clients “Do you currently 
smoke cigarettes?” with response codes “Yes, I currently smoke,”, “No, I 
quit smoking,” and “No, I never smoked.” 
In programs where CO measures were included, we used ≤9 ppm to 
verify non-smoking status. Earlier guidelines for biochemical verifica-
tion of smoking status recommended using a cutoff from 8 to 10 ppm 
(Benowitz et al., 2002). More recent guidelines recommend a range of 
5–6 ppm while commenting that higher cutoffs may be needed where 
environmental exposure is high (Benowitz et al., 2019). Indoor smoking 
is not permitted in public buildings in California, including residential 
SUD programs, however the rate of smoking among clients is very high 
(59.6% in the current sample), and outdoor smoking on program 
grounds is common. Residential SUD clients, even non-smokers, are 
likely to be exposed to secondhand smoke in the course of entering and 
exiting buildings, or during breaks where clients socialize in designated 
outdoor smoking areas. Given the high rate of smoking and likelihood of 
secondhand smoke exposure, we used the more relaxed (≤ 9 ppm) 
cutoff. Clients who self-reported as non-smokers, but registered CO 
above the cutoff were regarded as “probable smokers,” and treated as 
current smokers for analyses. Clients also reported whether they had 
used e-cigarettes, smokeless tobacco, cigars or little filtered cigars in the 
past month. These items were used to calculate the proportion who used 
at least one tobacco product in the past month. Current smokers also 
reported number of cigarettes per day (CPD), whether they had made a 
quit attempt in the past year, and whether they were thinking about 
quitting smoking in the next 30 days. 
The survey asked clients about four tobacco-related services they 
may have received in the treatment program. All clients reported 
whether any staff member had asked if they smoke. Current smokers 
reported whether they had attended a smoking cessation support group 
(yes/no), and how often their counselor encouraged them to quit 
smoking or arranged an appointment to discuss quitting. The last two 
items were dichotomized as Never vs. Occasionally/Often/Very Often/ 
Always. If a client received one or more of these three services, they 
were coded as having received any counseling. Smokers who received a 
referral to either a smoking cessation specialist or a telephone quitline 
were coded as having received any referral. Last, smokers who received 
any nicotine replacement therapy (NRT) or other cessation medication 
were coded as receiving any NRT/Pharmacotherapy. 
2.4.2. Staff measures 
In addition to demographic characteristics, staff self-reported current 
smoking status, but without biochemical verification. Staff reported-
whether they had used e-cigarettes, smokeless tobacco, cigars or little 
filtered cigars in the past month. These items were used to calculate the 
proportion who used any tobacco product in the past month. Current 
smokers reported number of cigarettes per day (CPD), whether they had 
made a quit attempt in the past year, and whether they were thinking 
about quitting smoking in the next 30 days. 
Staff also completed the Smoking Knowledge, Attitudes and Practices 
(S-KAP) survey which includes multi-item scales reflecting beliefs about 
addressing tobacco use in SUD treatment (α = 0.74), self-efficacy in 
providing tobacco-related services (α = 0.72), and practices (α = 0.91) 
used by counselors to address smoking with clients (Delucchi, Tajima, & 
Guydish, 2009). The Belief scale includes 7 items which ask, for 
example, whether quitting smoking while in treatment threatens sobri-
ety and whether counseling motivates clients to quit. The Self-Efficacy 
scale includes 9 items concerning skills in providing tobacco-related 
services, for example, that clients want to quit and are likely to follow 
the clinician’s advice. The Practice scale includes 9 items which ask, for 
example, how often the counselor asks, advises, or assists clients with 
quitting smoking. All responses are scored from 1 to 5, and the mean of 
items comprises the scale score. Higher scale scores reflect more positive 
beliefs about addressing smoking, greater self-efficacy and greater use of 
practices to address smoking. Scale items, response codes, and mean 
(SD) values for the current staff sample are included in Supplemental 
Table 1. 
Residential SUD programs include both clinical and non-clinical staff 
however, only clinical staff would deliver tobacco-related services. 
Consequently, the Beliefs scale was completed by all staff, while only 
clinical staff completed the Self-efficacy and Practice scales. Clinical 
staff were those who had an active client caseload in the past month 
(values ≥ 1) and/or had conducted group or individual sessions in the 
past week (values ≥ 1). 
2.4.3. Program tobacco policy 
Program directors reported on the tobacco policy at each program 
was measured using a survey developed for this study. The survey 
included 20 items drawn from prior research concerning tobacco free 
grounds (Muilenburg et al., 2016), smoking among staff (Cookson et al., 
2014; Skelton et al., 2017), and staff and clients smoking together 
(Guydish, Campbell, Yip, & Delucchi, 2017). Each item is assigned a 
score of 1 if the response is aligned with strategies that discourage 
smoking. For example, the program receives points if clients (1 point) 
and staff (1 point) are not permitted to smoke outdoors on program 
grounds, and if the program provides tobacco-related screening (1 
point), advice (1 point), counseling (1 point), referral (1 point) or edu-
cation (1 point). The total possible score is 20, and in this sample of 24 
programs the tobacco policy scores ranged from 3 to 19 (median = 11). 
The scale items and scoring are found at https://doi.org/10.6084/m9. 
figshare.14550981.v1 
2.5. Data analysis 
We report demographic and tobacco use characteristics, aggregated 
across programs, for clients and staff. For clients we report the propor-
tion who received each of the four tobacco-related services and, for staff, 
the mean values for the three scales. 
We assessed the association between staff use any tobacco product in 
each program as the predictor and each of 8 outcomes (client use of any 
tobacco product, the four client-reported tobacco service measures, and 
the three staff-reported measures) using general linear models. The unit 
of the analysis was the clinic (N = 24), limiting sample size. The small 
sample size hindered the number of control variables included in the 
models. We controlled for two covariates likely to influence associations 
between staff smoking rates and client receipt of tobacco-related ser-
vices. These are the proportion of clients in each program who were 
covered by Medi-Cal and for whom cessation services were covered as a 
healthcare benefit, and the strength of program tobacco policies which 
may encourage quitting and reduce tobacco-related disease in this 
population (Marynak et al., 2016). Unadjusted estimates (with 95% CI) 
and adjusted estimates (with 95% CI) were presented. We classified 47 
cases as “probable smokers” due to discordant self-report and expired 
CO measures, and these cases were included in the main analyses as 
current smokers. As it is possible that these cases were not smokers, we 
repeated multivariate analyses testing the association between staff and 
client smoking prevalence, but excluding the 47 “probable smokers.” 
Last, we graphically represent the association between staff use of any 
tobacco product in each program and client use of any tobacco product 
in its respective program using a scatterplot. 
3. Results 
3.1. Demographic and tobacco use characteristics 
Across all programs, 639 clients completed the survey, representing 
84% of those eligible. Participation rates in individual programs ranged 
from 67% to 100%. Demographic, insurance, and reason for treatment 
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variables are given in Table 1. With non-smoking status verified by 
expired CO ≤ 9 ppm, client smoking prevalence was 67%. This preva-
lence includes 47 cases who self-reported as non-smokers but registered 
above the CO cutoff. An additional 26 cases reported no current use of 
combustible cigarettes, but used other tobacco products in the past 
month, giving a total of 454 (71%) tobacco users. 
Across all programs, 363 staff completed the survey, representing 
80% of those eligible. Participation rates in individual programs ranged 
from 59% to 100%. Staff demographic characteristics are reported in 
Table 1. Nearly two-thirds (65.4%) had clinical responsibilities. Among 
staff, 21.8% self-reported as current smokers, and 32% had used any 
tobacco product in the past month. 
Among current smokers, for clients and staff respectively, mean (SD) 
CPD was 9.8 (7.7) and 7.9 (5.7), proportions reporting a quit attempt in 
the past year were 59.8% and 65.8%, and proportions thinking of 
quitting smoking in the next 30 days were 32.4% and 39.2% (data not 
shown). As the Tobacco Policy Measure was developed for this study, we 
assessed the correlation between the policy measure (reported by pro-
gram directors) and the Belief, Self-Efficacy, and Practice scales (re-
ported by program staff) in the 24 programs. The policy measure was 
positively and significantly correlated with the Belief (r = 0.52, p < .01) 
and Practice (r = 0.42, p < .05) scales, but the correlation fell short of 
significance for the Self-Efficacy scale (r = 0.39, p = .063). These find-
ings suggest that tobacco policy measure reported by program directors 
was positively associated with tobacco-related beliefs and practices re-
ported by staff in the same program. 
3.2. Tobacco related services measures reported by clients and staff 
Table 2 summarizes, in the first column, the proportion of clients 
who were asked about their smoking status, and who received tobacco- 
related counseling, medication, or referral. The denominator varies 
because smoking status was asked of all clients (N = 639), while receipt 
of tobacco-related services was asked only of those who reported current 
smoking status or quitting smoking while in the treatment program (n =
466). Among all clients, 64.1% had been asked their smoking status. 
Among tobacco users or those who quit in the program, 57.1% had 
received tobacco-related counseling, 26% had received cessation 
medication, and 32.5% had received tobacco-related referral. 
The rightmost column of Table 2 shows mean (SD) values for the 
three S-KAP scales. The denominator varies by scale, as the belief scale 
items were asked of all staff (N = 363) while the efficacy and practice 
scale items were asked of clinical staff (n = 236). All mean scale scores 
shown occur on a scale of 1 to 5, where higher scores indicate greater 
belief about treating tobacco use, and greater ability to do so. 
3.3. Association between staff tobacco, client tobacco use, and tobacco 
service measures 
Results of analyses for associations between staff use of any tobacco 
product and both client and staff outcome measures are shown in 
Table 3. At the top of the table, the first unadjusted estimate shows that 
the rate of staff tobacco use was positively associated with the rate of 
client tobacco use (beta = 0.63, CI 0.13, 1.12). After adjusting for the 
proportion of clients who were covered by Medi-Cal and strength of the 
tobacco policy in each program, this association remained significant 
Table 1 
Demographic characteristics for clients (N = 639) and staff (N = 363) across 24 
SUD treatment programs.   
Mean (SD) or n (%) 
Clients (n = 639) Staff (n = 363) 
Age, mean 38.5 (11.7) 44.6 (12.5) 
Gender, %   
Male 460 (72.2%) 122 (33.7%) 
Female 166 (26.1%) 233 (64.4%) 
Other 11 (1.7%) 7 (1.9%) 
Race/ethnicity, %   
Hispanic/Latino 255 (39.9%) 111 (30.8%) 
Black or African American 126 (19.7%) 81 (22.4%) 
White or Caucasian 193 (30.2%) 124 (34.4%) 
Other/Multiplea 65 (10.2%) 45 (12.5%) 
Education, %   
No HS diploma/GED 164 (25.7%) 7 (2.0%) 
High school diploma or GED 223 (34.9%) 52 (14.7%) 
Some college or technical/trade schoolb 186 (29.1%) 127 (36.0%) 
Bachelor’s or Associate’s 66 (10.3%) 104 (29.5%) 
Graduate degreec  63 (17.9%) 
Smoking Status, %   
Current Smoker 381 (59.6%) 79 (21.8%) 
Probable smokerd 47 (7.4%)  
Former Smoker 150 (23.5%) 177 (48.8%) 
Never Smoker 61 (9.6%) 107 (29.5%) 
Any E-cigarette use past month 47 (23.4%) 61 (16.8%) 
Any Tobacco Product use past month 454 (71.1%) 116 (32.0%) 
Healthcare coverage, %   
Medi-Cal 453 (70.9%)  
Medicare 30 (4.7%)  
Employer, family, or other plane 38 (6.0%)  
No healthcare coverage 71 (11.1%)  
Don’t know/not sure if covered 47 (7.4%)  
In treatment for, %   
Substance use 356 (56.2%)  
Both substance use and mental healthf 189 (29.8%)  
Other reason for treatment 89 (14.0%)  
Clinical Staff, n (%)  236 (65.4%)  
a Client category includes American Indian or Alaska Native (2.7%), Asian/ 
Pacific Islander (1.7%), and those reporting multiple (3.8%) and “other” (2.0%) 
race/ethnicity. Staff category includes American Indian or Alaska Native (0.8%), 
Asian (2.2%), Native Hawaiian/Pacific Islander (1.1%), those reporting multiple 
(4.2%), and “other” (4.2%) race/ethnicity  
b For staff, this category includes cases reporting college coursework related to 
counseling licensure.  
c Graduate training was not asked of clients  
d Self-reported as non-smokers but registered >9 ppm on expired CO measure.  
e Includes cases reporting another source of health insurance (2.8%) and those 
reporting that source of health insurance was unknown (1.1%)  
f In one of the projects, response codes for this item included “mental health 
only” (with 3.2%) responses. To represent the entire sample, these cases are 
collapsed into “Both substance use and mental health disorders.”  
Table 2 
Tobacco-related services reported by clients and staff across 24 SUD treatment 
programs.   
Mean (SD) or n (%) 
Clients Staff 
Client was asked about smokinga 409 (64.1%) N/A 
Client received any counselingb 265 (57.1%) N/A 
Client received any cessation medicationsb 121 (26.0%) N/A 
Client received any referralb 151 (32.5%) N/A 
Staff belief scalec N/A 3.5 (0.70) 
Staff self- efficacy scaled N/A 3.2 (0.69) 
Staff practice scaled N/A 2.6 (1.03)  
a All clients (N = 639).  
b Self-reported current smokers and former smokers who quit in the program 
(N = 466).  
c All staff (N = 363).  
d Clinical staff (N = 236).  
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(beta = 0.59, 95% CI 0.06–1.12, p = .03). In the sensitivity analysis, 
excluding the 47 “probable smokers,” the finding was the same (beta =
0.64, 95% CI 0.13–1.15, p = .017, data not shown). 
The rightmost column of Table 3 shows the association of staff to-
bacco use with other outcomes, adjusting for the proportion of clients 
covered by Medi-Cal, and controlling for the strength of program to-
bacco policies. The prevalence of tobacco use among staff was signifi-
cantly and inversely associated with client receipt of tobacco-cessation 
counseling, staff beliefs about having clients quit in drug treatment, and 
staff self-efficacy to assist clients with quitting. 
Prevalence of past month tobacco use among both staff and clients in 
the 24 programs is plotted in Fig. 1. The program at bottom left had 0% 
of staff and 20% of clients reporting recent use of tobacco products. The 
program at far right had 100% of staff and 86% of clients reporting use 
of tobacco products. 
4. Discussion 
In this sample of 24 publicly-funded California residential SUD 
treatment programs, staff smoking ranged from 0% to 57.1% by pro-
gram and, collapsed across all programs, staff smoking prevalence was 
21.8%. This prevalence is in contrast to the California general popula-
tion smoking rate of 11.2% in 2018 (Centers for Disease Control and 
Prevention, 2018). We consider not only use of combustible cigarettes, 
but also use of other tobacco products. In the current sample, prevalence 
of use of any tobacco product among staff ranged from 0% to 100% and, 
collapsed across programs was 32%. 
One explanation for elevated rates of staff smoking and use of other 
tobacco products may be the tradition of hiring persons who are in re-
covery from substance use. Doing so offers an available recruitment 
pool, dedicated to SUD treatment, and with lived experience relevant to 
the counseling mission (Guydish et al., 2017). However, if the use of 
tobacco products is high among clients, and if those clients enter the 
treatment workforce, then use of tobacco products may also be high in 
the workforce. 
Multivariate analyses found that higher rates of staff tobacco use 
were associated with higher rates of client tobacco use, and with fewer 
clients receiving tobacco-related counseling. In programs with higher 
rates of staff tobacco use, staff were less likely to believe that clients 
should quit smoking in the treatment program, and had lower self- 
efficacy to address smoking among clients. 
Our analyses suggest that greater tobacco use among staff is associ-
ated with fewer tobacco services among clients, but it may depend on 
Table 3 
Association between prevalence of tobacco use among staff and selected client 









Client tobacco use 
prevalence 
0.63 (0.13, 1.12) 0.016 0.59 (0.06, 
1.12) 
0.030 
Client was asked 
about smoking 
− 0.13 (− 0.53, 
0.27) 
0.516 − 0.11 (− 0.49, 
0.27) 
0.548 
Client received any 
counseling 
− 0.74 (− 1.15, 
− 0.33) 
0.001 − 0.69 (− 1.12, 
− 0.27) 
0.003 
Client received any 
cessation 
medications 
− 0.28 (− 0.80, 
0.24) 
0.272 − 0.18 (− 0.69, 
0.32) 
0.456 
Client received any 
referral 
− 0.41 (− 0.84, 
0.03) 
0.065 − 0.35 (− 0.76, 
0.07) 
0.100 
Staff belief scale − 0.02 (− 0.02, 
− 0.01) 





− 0.01 (− 0.02, 
− 0.01) 
<0.001 − 0.01 (− 0.02, 
− 0.01) 
<0.001 
Staff practice scale − 0.01 (− 0.02, 
− 0.001) 
0.041 − 0.01 (− 0.02, 
0.001) 
0.083 
Bolded values reflect associations significant at p > 0.05 
a Adjusted for % Med-Cal clients and Tobacco policy strength score.  
Fig. 1. Plot of staff tobacco use prevalence v. client tobacco use prevalence (N = 24 programs).  
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who is asked. When staff were asked about tobacco services they provide 
to clients, we see the association in unadjusted analysis but significant is 
lost in the adjusted analysis. This loss of significance may indicate no 
relationship, or a relationship that could be seen only in a larger sample. 
When clients were asked about services they received, the association 
was present and unambiguous. Reports by clients regarding tobacco- 
related services they received in a program may be more reliable than 
staff reports about tobacco services they provide, to the degree that they 
reflect what services clients actually received, or what services they 
recognized as tobacco-related. 
The current findings are broadly consistent with literature showing 
that staff who smoke held more negative views about addressing 
smoking (Bobo et al., 1995; Campbell et al., 1998), more often believed 
that clients were not interested in quitting smoking (Skelton et al., 
2017), and were less likely to implement smoking related client services 
(Bobo et al., 1995; Campbell et al., 1998; Knudsen & Studts, 2010; 
Laschober et al., 2015). 
Study limitations include small sample size (N = 24), which restricts 
the number of covariates that can be controlled in analyses. The two 
covariates selected, whether clients had Medi-Cal insurance that 
covered smoking cessation services and the strength of the tobacco 
policy in each program, have face validity. However, other covariates 
could be tested and, particularly in a larger sample of programs, could 
result in different findings. All participating programs were recruited in 
California, which has the lowest general population smoking rate 
(11.2%) of any US State excepting Utah, and a robust state tobacco 
control program (Centers for Disease Control and Prevention, 2018; 
Roeseler & Burns, 2010). If staff and client tobacco use rates are influ-
enced by statewide smoking rates, then our findings concerning preva-
lence of staff smoking may underestimate staff smoking rates in states 
where population smoking rates are higher. The study sample includes 
adult residential SUD programs only which, in California, comprise 19% 
of all publicly funded treatment programs (Guydish et al., 2020). 
Findings may not extend to outpatient, methadone, or adolescent 
focused programs. All programs in this sample were publicly-funded 
programs. Higher rates of smoking, or of use of any tobacco product, 
may be more likely in publicly-funded treatment systems. Hospital- 
based programs, Veteran’s Affairs programs, and private healthcare 
systems providing their own chemical dependence services may include 
more professional and medical staff where smoking rates are low. 
However, two-thirds of current SUD treatment occurs in the public 
sector (Mark, Levit, Vandivort-Warren, Coffey, & Buck, 2007; Mechanic, 
Schlesinger, & McAlpine, 1995), so high rates of smoking among SUD 
staff may occur in the preponderance of programs. The measure of to-
bacco policy strength was created for this research, and has not been 
validated. Last, programs in this study were recruited for research on 
tobacco-free grounds, and had expressed interest in better addressing 
tobacco use among clients. Findings may be conservative if other pro-
grams not included in the study tended to have little or no interest in 
changing practices to address smoking. 
We are aware of no other study in which staff and client tobacco- 
related variables were assessed in a similar or larger number of SUD 
treatment programs, and where staff tobacco use was assessed for re-
lationships with both client and staff variables. Findings show that 
higher rates of tobacco use among staff are associated with higher rates 
of tobacco use and lower rates of tobacco-related services among clients. 
SUD treatment programs, and agencies that fund and regulate those 
programs, should work to reduce use of all tobacco products among 
staff. This is in the interest or the treatment workforce as well as in the 
interest of the treatment clients. Smoke-free workplace policies, which 
reduce smoking (Fichtenberg & Glantz, 2002) and increase health equity 
(Hafez, Gonzalez, Kulik, Vijayaraghavan, & Glantz, 2019), should be 
implemented in SUD settings no less than they are implemented in 
virtually every other healthcare setting. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.jsat.2021.108496. 
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